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were selected for inclusion in the Lupus Impact Tracker, a PRO intended for clinical
practice use to monitor the impact of SLE on patients’ lives and well being.
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OBJECTIVES: A daily assessment of the speed of action and effectiveness of treat-
ment of a combination of paracetamol and codeine in patients suffering from
intense pain, which has progressed since less than 7 days.METHODS: Amulticen-
tre longitudinal observational prospective study carried out inmetropolitan France
using data collected by general practitionerswho agreed to participate. RESULTS:A
total of 574 patients treated by a paracetamol-codeine combination (600mg/50mg
and 400mg/20mg) were included. The severity of pain measured at inclusion using
a visual numeric scalewas 71.28. The severity of painmeasured after half a day of
treatment was 5.611.87 and 5.28  1.86 at the end of the first 24 hours of treat-
ment. A significant improvement in pain was observed from the first half-day
(p0.001). The severity of pain on the 2nd, 4th and 7th evenings was respectively
4.081.85; 2.761.76 and 1.79 1.69 On D1, 69.7% declared treatment to be effec-
tive, 61.04%were satisfiedwith their treatment and 79.26%did not observe any side
effects to the treatment. On D7, 96.15% (D3, 91.3% ) declared treatment to be effec-
tive, 87.10%were satisfiedwith their treatment and 88.96%did not observe any side
effects to the treatment. 8 out of 10 patients did not complain about side effects
related to the treatment. CONCLUSIONS: A reduction in pain within the first 12
hours showed the pertinence of treatment using a paracetamol-codeine combina-
tion. This pertinencewas confirmed by two-thirds patients who declared the treat-
ment to be effective from the 1st day, and 91% of them declared this on the 3rd day
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OBJECTIVES: The diabetic peripheral neuropathy (DPN) is the most common
chronic complication of diabetes. Neuropathic pain tends to be severe, chronic, and
has a hugely negative impact on the physical and emotional functioning, and over-
all well-being of the patient. This study was performed to evaluate the scope of
pain and quality of life among patients with painful diabetic peripheral
neuropathy.METHODS: A cross-sectional, observational study was carried out on
type 2 diabetic patients from 40 medical centers throughout Korea. The standard-
ized questionnaires such as Michigan Neuropathy Screening Instrument (MNSI),
Brief Pain Inventory-short form (BPI-sf), MOS 6-items Sleep Scale and EuroQoL
(EQ-5D) were used to diagnosis and estimate the quality of life in people with DPN.
A patient with DPN was defined as the patients who showed positive patients
medical records or neuropathic symptoms (MNSI2) and positive response on the
basic neurological examination (Monofilament test). RESULTS: Among 4,000 dia-
betic patients, 33.5% had DPN. Of those 1,338 DPN patients, 874 (65.3%) took pain
medications or had 1 worst pain scores (BPI-sf, 0-10 scales). Patients who took
pain medications or had 1 worst pain scores were 6310.6 years old (57.9% fe-
male), had diabetes for 138.0 years and DPN for 4.03.3 years. Average andWorst
Pain score were 2.92.3 and 4.93.1. Pain interference index were higher in pa-
tientswho took painmedications or had1worst pain scores (2.42.6 and 0.20.8,
respectively, P0.0001). Pain substantially interfered with general activity, mood,
walking, normal work, relationships, sleep, and enjoyment of life. These patients
reported greater sleep problems compared with DPN patients without pain. The
mean EQ-5D utility score was 0.60.2. CONCLUSIONS: This study found that pain
associated with diabetic neuropathy is a significant medical issue that has a sub-
stantial impact on the quality of life of many people with this condition.
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OBJECTIVES: To assess health status, treatment patterns and quality of life in
patientswith hereditary coagulopathies inKazakhstan.METHODS: Postal and tele-
phone health survey. Questionnaires were distributed in May - August 2009. The
questionnaire contained questions on clotting factor level, number of bleeding,
number of injections of clotting factors, ways of receiving medications, number of
ambulance calls and hospitalizations, and the way of administration ofmedicines.
The patients’ education level and employment data was collected. Analysis was
performed with 2 and Student’s criteria. RESULTS: 626 completed questionnaires
were received by September, 2009. Hemophilia A was reported by 486 responders
(77.6%). 426 patients (68%) were adults. Mean age was 25.4 years. 60 patients with
hemophilia A and B (11.6%) had a level of coagulation factors lower then 1%, i.e.
they had a severe form of disease. The presence of antibodies was detected in 68
patients (11%). 87.8% of patients experienced bleeding in the last month. The me-
dian of a number of bleeding among all bled patients was 2. 84.4% of patients used
clotting factors in the last month. The median number of injections of clotting
factor VIII in patients with hemophilia A was 2 (standard frequency is 12). 7.2% of
patients called for an ambulance in a lastmonth (medium frequency of calls in last
month – 2). 7.4% of patients were hospitalized during last month (medium fre-
quency of hospitalization – 2). 564 (90.2%) of patients perform the injections of
clotting factor themselves. 12.8% of patients reported use of prophylaxis scheme of
treatment hemophilia, 70.6% of patients reported use of “on demand” scheme.
CONCLUSIONS: Results of survey showed very low rate of treatment of hemophilia
with proper prophylactic scheme (less than 13%of patients). The rate of ambulance
calls and hospitalizations is comparatively low. Themajority of patients introduce
the factors themselves.
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OBJECTIVES: To assess health status, treatment patterns and quality of life in
patients with hereditary coagulopathies in Ukraine.METHODS: Postal health sur-
vey. Questionnaires were distributed in May - August 2009. The questionnaire
contained questions on clotting factor level, number of bleeding, injections of clot-
ting factors, ways of receiving medications, number of ambulance calls and hospi-
talizations, and the way of administration of medicines. Analysis of experimental
data was performed with such statistical parameters as 2 and Student’s criteria.
RESULTS: 154 completed questionnaires were received by September, 2009. Hemo-
philia Awas reported by 103 responders (67%). 126 (81.8%) patientswere adults. The
detection of a level of coagulation factors during last year was done in 50 (40.4%)
patients with hemophilia A and B. 24 (19.4%) patients with hemophilia A and B had
a level of coagulation factors lower then 1%, i.e. they had a severe form of disease.
The presence of antibodies was detected in 27 patients (17.5%). 80.6% of patients
experienced bleeding during the last month (median - 4). 51.4% of patients with
hemophilia A used clotting factor VIII during last month. The median number of
injections of clotting factor VIII in patients with hemophilia A was 4 (standard
frequency is 12). 36.4% of patients called for an ambulance during last month
(medium frequency – 1). 49.3% of patients were hospitalized during last month
(medium frequency – 1). Only 23 (15%) of patients performed the injections of
clotting factor themselves. Only 1.3% of patients reported use of prophylaxis
scheme of treatment hemophilia, 85.7% of patients reported use of “on demand”
scheme. CONCLUSIONS: Results of survey showed very low rate of treatment of
hemophilia with proper prophylactic scheme (about than 1.3% of patients). The
rate of ambulance calls and hospitalizations is extremely high. The majority of
patients introduce the factors in hospitals.
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OBJECTIVES: To assess health status, treatment patterns and quality of life in
patientswith hereditary coagulopathies inKazakhstan.METHODS: Postal and tele-
phone health survey. Questionnaires were distributed in May - August 2009. The
questionnaire contained questions on clotting factor level and presence of anti-
bodies to it, number of bleeding in last month, number of injections of clotting
factors per month, names of used medications, ways of receiving medications,
number of ambulance calls and hospitalizations, and the way of administration of
medicines (self-administration of administration at a ambulatory/hospital). The
patients’ education level and employment datawas collected. Health-related qual-
ity of life was assessed with self-administrated validated version of Russian ver-
sion of Euroqol-5D questionnaire. Comparisonwasmadewith health-related qual-
ity of life of Russian patients data (P.Vorobeyv et. al., 2008, data of 1003 patientswas
used in analyses). RESULTS: 626 completed questionnaires were received by Sep-
tember, 2009. Health-related quality of life was assessed for patients older than 11
years (n 514). More than half of patients reported problems within each of EQ-5D
dimensions of health. Thus 63.9% of patients reported of problems (moderate and
severe) with mobility (63.9% of Russian patients, p0.05); 65.2% of patients in-
formed of difficulties with self-care (35.5% of Russian patients, p0.05); 70.1% of
patients had difficultieswith usual activity (61.9% of Russian patients, p0.05); 74%
of patients reported of presence of pain or discomfort (78.4% of Russian patients,
p0.05); 27.3% of patients had an anxiety or depression (54.2% of Russian patients,
p0.05). The average value of quality of life evaluated with visual-analog scale
(VAS) was 0.53 (SD 0.18), median - 50. CONCLUSIONS: Results of the study shown
high rate of problemswithmobility, usual activity and high rate of pain/discomfort
and low rate of problem with anxiety/depression.
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OBJECTIVES: To assess epidemiology of anemia cased by chronic renal failure in
patients on dialysis and patient’s quality of life. METHODS: Health survey of pa-
tients in dialysis departments of 23 regions. About 1400 questionnaires were dis-
tributed in May - June 2010. The form contained following questions: personal
information (name, age, patients’ education and employment), medical data (di-
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